317 related articles for article (PubMed ID: 18089706)
1. Inactivation of glycogen synthase kinase-3beta contributes to brain-derived neutrophic factor/TrkB-induced resistance to chemotherapy in neuroblastoma cells.
Li Z; Tan F; Thiele CJ
Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3113-21. PubMed ID: 18089706
[TBL] [Abstract][Full Text] [Related]
2. Genetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrkB rescue of neuroblastoma cells from chemotherapy-induced cell death.
Li Z; Jaboin J; Dennis PA; Thiele CJ
Cancer Res; 2005 Mar; 65(6):2070-5. PubMed ID: 15781614
[TBL] [Abstract][Full Text] [Related]
3. Perifosine-induced inhibition of Akt attenuates brain-derived neurotrophic factor/TrkB-induced chemoresistance in neuroblastoma in vivo.
Li Z; Oh DY; Nakamura K; Thiele CJ
Cancer; 2011 Dec; 117(23):5412-22. PubMed ID: 21590687
[TBL] [Abstract][Full Text] [Related]
4. Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway.
Jaboin J; Kim CJ; Kaplan DR; Thiele CJ
Cancer Res; 2002 Nov; 62(22):6756-63. PubMed ID: 12438277
[TBL] [Abstract][Full Text] [Related]
5. A novel mechanism of hepatocellular carcinoma cell apoptosis induced by lupeol via Brain-Derived Neurotrophic Factor Inhibition and Glycogen Synthase Kinase 3 beta reactivation.
Zhang L; Tu Y; He W; Peng Y; Qiu Z
Eur J Pharmacol; 2015 Sep; 762():55-62. PubMed ID: 26004524
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death.
Li Z; Zhang J; Liu Z; Woo CW; Thiele CJ
Cell Death Differ; 2007 Feb; 14(2):318-26. PubMed ID: 16778834
[TBL] [Abstract][Full Text] [Related]
7. Resistance to chemotherapy mediated by TrkB in neuroblastomas.
Ho R; Eggert A; Hishiki T; Minturn JE; Ikegaki N; Foster P; Camoratto AM; Evans AE; Brodeur GM
Cancer Res; 2002 Nov; 62(22):6462-6. PubMed ID: 12438236
[TBL] [Abstract][Full Text] [Related]
8. Brain-derived Neurotrophic Factor Promotes Growth of Neurons and Neural Stem Cells Possibly by Triggering the Phosphoinositide 3-Kinase/ AKT/Glycogen Synthase Kinase-3β/β-catenin Pathway.
Li XT; Liang Z; Wang TT; Yang JW; Ma W; Deng SK; Wang XB; Dai YF; Guo JH; Li LY
CNS Neurol Disord Drug Targets; 2017; 16(7):828-836. PubMed ID: 28524001
[TBL] [Abstract][Full Text] [Related]
9. GSK-3beta reactivation with LY294002 sensitizes hepatoma cells to chemotherapy-induced apoptosis.
Beurel E; Kornprobst M; Blivet-Van Eggelpoël MJ; Cadoret A; Capeau J; Desbois-Mouthon C
Int J Oncol; 2005 Jul; 27(1):215-22. PubMed ID: 15942663
[TBL] [Abstract][Full Text] [Related]
10. Brain-derived neurotrophic factor prevents phencyclidine-induced apoptosis in developing brain by parallel activation of both the ERK and PI-3K/Akt pathways.
Xia Y; Wang CZ; Liu J; Anastasio NC; Johnson KM
Neuropharmacology; 2010 Feb; 58(2):330-6. PubMed ID: 19887077
[TBL] [Abstract][Full Text] [Related]
11. Differential modulation of Akt/glycogen synthase kinase-3beta pathway regulates apoptotic and cytoprotective signaling responses.
Nair VD; Olanow CW
J Biol Chem; 2008 May; 283(22):15469-78. PubMed ID: 18387957
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase B/Akt-dependent phosphorylation of glycogen synthase kinase-3beta in irradiated vascular endothelium.
Tan J; Geng L; Yazlovitskaya EM; Hallahan DE
Cancer Res; 2006 Feb; 66(4):2320-7. PubMed ID: 16489037
[TBL] [Abstract][Full Text] [Related]
13. Spotlight on Coenzyme Q10 in scopolamine-induced Alzheimer's disease: oxidative stress/PI3K/AKT/GSK 3ß/CREB/BDNF/TrKB.
Abuelezz SA; Hendawy N
J Pharm Pharmacol; 2023 Aug; 75(8):1119-1129. PubMed ID: 37315215
[TBL] [Abstract][Full Text] [Related]
14. BDNF promotes the growth of human neurons through crosstalk with the Wnt/β-catenin signaling pathway via GSK-3β.
Yang JW; Ru J; Ma W; Gao Y; Liang Z; Liu J; Guo JH; Li LY
Neuropeptides; 2015 Dec; 54():35-46. PubMed ID: 26311646
[TBL] [Abstract][Full Text] [Related]
15. P53/PUMA are potential targets that mediate the protection of brain-derived neurotrophic factor (BDNF)/TrkB from etoposide-induced cell death in neuroblastoma (NB).
Hua Z; Zhan Y; Zhang S; Dong Y; Jiang M; Tan F; Liu Z; Thiele CJ; Li Z
Apoptosis; 2018 Aug; 23(7-8):408-419. PubMed ID: 29959561
[TBL] [Abstract][Full Text] [Related]
16. Trk inhibitor attenuates the BDNF/TrkB-induced protection of neuroblastoma cells from etoposide in vitro and in vivo.
Li Z; Zhang Y; Tong Y; Tong J; Thiele CJ
Cancer Biol Ther; 2015; 16(3):477-83. PubMed ID: 25700942
[TBL] [Abstract][Full Text] [Related]
17. Role of connexin-43 in protective PI3K-Akt-GSK-3β signaling in cardiomyocytes.
Ishikawa S; Kuno A; Tanno M; Miki T; Kouzu H; Itoh T; Sato T; Sunaga D; Murase H; Miura T
Am J Physiol Heart Circ Physiol; 2012 Jun; 302(12):H2536-44. PubMed ID: 22505645
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase-3beta suppression eliminates tumor necrosis factor-related apoptosis-inducing ligand resistance in prostate cancer.
Liao X; Zhang L; Thrasher JB; Du J; Li B
Mol Cancer Ther; 2003 Nov; 2(11):1215-22. PubMed ID: 14617795
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor 1 protects human neuroblastoma cells SH-EP1 against MPP+-induced apoptosis by AKT/GSK-3β/JNK signaling.
Wang L; Yang HJ; Xia YY; Feng ZW
Apoptosis; 2010 Dec; 15(12):1470-9. PubMed ID: 20963499
[TBL] [Abstract][Full Text] [Related]
20. [Effects of tyrosine kinase receptor B and brain-derived neurotrophic factor on chemoresistance in neuroblastoma].
Li AM; Zhang JH; Zhang JH; Zhang KR; Rong DJ
Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):535-9. PubMed ID: 17044982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]